Extended-Spectrum β-Lactamases in Enterobacteriaceae in Buenos Aires, Argentina, Public Hospitals
Open Access
- 1 September 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (9) , 2864-2867
- https://doi.org/10.1128/aac.47.9.2864-2867.2003
Abstract
Resistance to extended-spectrum cephalosporins is often associated with plasmid encoded extended spectrum β-lactamases (ESBL). In order to evaluate the prevalence and diversity of ESBLs in enterobacteria in our city, a 1-month-period survey was carried out from April to May 2000. Extended-spectrum-cephalosporin-resistant strains, isolated from inpatient clinical specimens other than stools, were collected among 17 participating hospitals. From a total of 427 enterobacterial strains that were collected during this period, 39 were extended-spectrum cephalosporin resistant. The National Committee for Clinical Laboratory Standards' Screening and Confirmatory Tests for ESBL production were performed using cefotaxime and ceftazidime; cefepime and cefepime-clavulanic acid-containing disks were included. β-Lactamases were characterized by isoelectric focusing and PCR amplification using specific primers. Three different ESBLs were detected: SHV-related (4 isolates), PER-2-type (9 isolates), and CTX-M-2-related (26 isolates). Sequencing of the corresponding genes confirmed CTX-M-2 in 19 of 21 and CTX-M-31 (an allelic variant) in the remaining 2 of 21. CTX-M-2 (or its variant) was detected in all Escherichia coli , Enterobacter aerogenes , Serratia marcescens , Proteus mirabilis , and Providencia stuartii strains, while PER-2 was detected in Enterobacter cloacae , E. aerogenes , and Klebsiella pneumoniae ; SHV-related ESBL were found only in K. pneumoniae . These results clearly show that CTX-M-2 is the most prevalent ESBL produced by enterobacterial species isolated from public hospitals in Buenos Aires.Keywords
This publication has 26 references indexed in Scilit:
- Plasmidic Extended-Spectrum β-Lactamases in Vibrio cholerae O1 El Tor Isolates in ArgentinaAntimicrobial Agents and Chemotherapy, 2002
- Early Dissemination of CTX-M-Derived Enzymes in South AmericaAntimicrobial Agents and Chemotherapy, 2002
- Third-Generation Cephalosporin Resistance inShigella sonnei, ArgentinaEmerging Infectious Diseases, 2001
- Non-typhoid Salmonella spp. resistant to cefotaximeJournal of Antimicrobial Chemotherapy, 1995
- Extrachromosomal resistance in Gram-negative organisms: the evolution of β-lactamaseTrends in Microbiology, 1994
- Unusual multiresistant Vibrio cholerae 01 El Tor in ArgentinaThe Lancet, 1993
- A new plasmidic cefotaximase from patients infected withSalmonella typhimuriumInfection, 1992
- Molecular evolution of ubiquitous β‐lactamases towards extended‐spectrum enzymes active against newer β‐lactam antibioticsMolecular Microbiology, 1990
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975